Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Osaic Welcomes $705 Million True Wealth Advisors from LPL Financial
-
Soundview Financial Group Joins Osaic, Bringing $104 Million in Client Assets
-
Sachem Capital enters agreement to sell up to $18.45 million preferred stock
-
Osaic Launches PlanningHub: Next-Level Comprehensive Financial Planning Resource for Advisors
-
Serve Robotics (SERV) PT Lowered to $15 at Ladenburg Thalmann
-
Form 13F-NT LADENBURG THALMANN ASSET For: Sep 30
-
Merit Financial Advisors Strengthens Leadership Team to Accelerate Firm Growth and Advisor Success
-
Global Medical REIT prices $50 million preferred stock offering
-
Global Medical REIT Inc. Announces Pricing of Public Offering of 8.00% Series B Preferred Stock
-
Salarius Pharmaceuticals completes merger with Decoy Therapeutics
-
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
-
Ondas Holdings Reports Record Third Quarter 2025 Financial Results - Robust Growth Outlook Supported by Execution at OAS, Strategic Growth Program and Strong Global Demand for Autonomous Drone Systems
-
Strong Earnings and Biotech Resilience Define the Midweek Momentum
-
Salarius Pharmaceuticals prices $7 million public offering
-
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
-
Beeline lending unit reaches cash flow positive in October
-
Beeline’s Lending Entity Achieves Cash Flow Positive Month in October
-
Beeline’s Lending Entity Achieves Cash Flow Positive Month in October
-
Ladenburg Thalmann Upgrades NextCure Inc. (NXTC) to Buy
-
Alerus Financial Expands Osaic Institutions Relationship to Serve New Markets
-
Core Scientific Inc. (CORZ) PT Raised to $24.50 at Ladenburg Thalmann
-
Ladenburg Thalmann Starts Draganfly Inc (DPRO) at Buy
-
Four Pillars Investment Management Joins Osaic from Commonwealth with $143 Million in Client Assets
-
Financial Advisor Brian Collins Launches Legacy Investment Advisors & Wealth Management with Osaic
-
Gallagher Financial Joins Osaic, Bringing $194M in Client Assets
-
REVUP Private Wealth Chooses New York Financial Partners, Osaic
-
Hinck Private Wealth Management Joins Osaic from Commonwealth
-
Ladenburg Thalmann Downgrades Southern Co. (SO) to Neutral
-
Ladenburg Thalmann Assumes Immunic Inc. (IMUX) at Buy
-
Akari Therapeutics raises $2.5 million in direct offering
-
Akari Therapeutics Announces $2.5 Million Registered Direct Offering
-
Ladenburg Thalmann Starts Vornado Realty Trust (VNO) at Buy
-
Ladenburg Thalmann Starts Boston Properties Inc. (BXP) at Buy
-
Ladenburg Thalmann Upgrades WEC Energy Group (WEC) to Buy
-
Currenc Group raises up to $33 million in convertible note financing
-
Currenc Group Announces up to $33 Million Convertible Note Financing
-
Ladenburg Thalmann Assumes Saratoga Investment (SAR) at Neutral
-
$453 Million Pilot Rock Financial Advisors Joins Osaic from Ameriprise
-
Saratoga Investment Corp. Announces Fiscal Second Quarter 2026 Financial Results
-
Ondas Holdings closes $425 million stock offering with warrants
-
Ondas Holdings Inc. Announces Closing of $425 Million Offering
-
Vanilla Approved by Osaic as a Comprehensive Estate Planning Solutions Provider to Over 11,000 Advisors
-
Cellectar Biosciences raises $5.8 million through warrant exercise
-
Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
-
Ondas Holdings Inc. Successfully Prices a $425 Million Stock and Warrant Sale Above Market Price
-
Palisade Bio closes $138 million public offering to fund drug trial
-
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option
-
Palisade Bio prices $120 million stock offering at $0.70 per share
-
Palisade Bio Announces Pricing of Upsized $120 Million Underwritten Public Offering of Common Stock
-
Wealth.com Named Estate Planning Partner by Osaic’s National Planning Institute, Supporting 11,000 Financial Professionals

